Advertisement
Screener

CURIS, INC. (CRIS) Graph

CRIS Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $0.00; Revenue including tax (m); Research and development (m); Net income -$8.58M.
  • 2026-03-31: Revenue $0.00; Revenue including tax (m); Research and development (m); Net income -$24.20M.
  • 2025-12-31: Revenue $1.14M*; Revenue including tax (m); Research and development (m); Net income $19.36M*.
  • 2025-09-30: Revenue $3.18M; Revenue including tax (m); Research and development (m); Net income -$7.73M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CRIS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$0.00Operating income-$9.94MNet income-$8.58M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxResearch and developmentNet income
2026-06-30$0.00(m)(m)-$8.58M
2026-03-31$0.00(m)(m)-$24.20M
2025-12-31$1.14M*(m)(m)$19.36M*
2025-09-30$3.18M(m)(m)-$7.73M
2025-06-30$2.75M(m)(m)-$8.59M
2025-03-31$2.38M(m)(m)-$10.62M
2024-09-30$2.93M(m)(m)-$10.09M
2024-06-30$2.55M(m)(m)-$11.80M
2024-03-31$2.09M(m)(m)-$11.88M
2023-09-30$2.83M(m)(m)-$12.18M
2023-06-30$2.20M(m)(m)-$11.96M
2023-03-31$2.30M(m)(m)-$11.56M
2022-09-30$2.83M(m)(m)-$13.29M
2022-06-30$2.39M(m)(m)-$15.94M
2022-03-31$2.06M(m)(m)-$16.11M
2021-09-30$3.04M(m)(m)-$11.05M
2021-06-30$2.29M(m)(m)-$10.84M
2021-03-31$2.19M(m)(m)-$9.93M
2020-12-31$3.02M(m)(m)-$7.52M
2020-09-30$2.74M(m)(m)-$5.97M
2020-06-30$2.36M(m)(m)-$6.71M
2020-03-31$2.71M(m)(m)-$9.71M
2019-12-31$3.29M(m)(m)-$8.61M
2019-09-30$2.86M$2.86M(m)-$6.44M
2019-06-30$2.09M$2.09M(m)-$7.21M
2019-03-31$1.77M$1.77M(m)-$9.88M
2018-12-31$2.75M(m)(m)-$5.94M
2018-09-30$2.85M$2.85M(m)-$7.22M
2018-06-30$2.36M$2.36M(m)-$8.66M
2018-03-31$2.47M$2.47M(m)-$10.75M
2017-12-31$3.26M(m)(m)-$8.03M
2017-09-30$2.44M$2.44M(m)-$15.46M
2017-06-30$2.06M$2.06M(m)-$14.09M
2017-03-31$2.13M(m)(m)-$15.74M
2016-12-31$2.36M(m)(m)-$11.34M
2016-09-30$1.76M(m)(m)-$28.34M
2016-06-30$1.68M(m)(m)-$11.29M
2016-03-31$1.73M(m)(m)-$9.44M
2015-12-31$2.09M(m)(m)-$13.46M
2015-09-30$2.04M(m)(m)-$5.54M
2015-06-30$2.08M(m)$2.00M-$8.13M
2015-03-31$1.66M(m)(m)-$31.85M
2014-12-31$1.99M(m)$3.48M*-$5.69M
2014-09-30$1.76M(m)$3.71M-$5.58M
2014-06-30$4.80M(m)$3.33M-$1.90M
2014-03-31$1.28M(m)$3.15M-$5.56M
2013-12-31$1.52M(m)(m)-$4.20M
2013-09-30$7.20M(m)$4.17M-$1.87M
2013-06-30$5.40M(m)$3.17M-$1.29M
2013-03-31$871.43K(m)$2.63M-$4.96M
2012-12-31$1.69M(m)(m)-$12.37M
2012-09-30$577.76K(m)$3.04M-$3.39M
2012-06-30$4.35M(m)$4.50M-$2.89M
2012-03-31$10.36M(m)$5.24M$2.23M
2011-12-31$14.09M(m)(m)$6.06M
2011-09-30$147.12K(m)$3.04M-$4.21M
2011-06-30$392.87K(m)$3.14M-$4.91M
2011-03-31$133.54K(m)$3.06M-$6.80M
2010-09-30$3.24M(m)$3.01M-$1.51M
2010-06-30$98.63K(m)$2.24M-$2.10M

Revenue and expense 6 month

Period endRevenueRevenue including taxResearch and developmentNet income
2026-06-30$0.00(m)(m)-$32.78M
2025-06-30$5.13M(m)(m)-$19.21M
2024-06-30$4.63M(m)(m)-$23.68M
2023-06-30$4.49M(m)(m)-$23.52M
2022-06-30$4.45M(m)(m)-$32.05M
2021-06-30$4.47M(m)(m)-$20.77M
2020-06-30$5.07M(m)(m)-$16.42M
2019-06-30$3.86M$3.86M(m)-$17.10M
2018-06-30(m)$4.83M(m)-$19.41M
2017-06-30$4.19M$4.19M(m)-$29.83M
2016-06-30$3.41M(m)(m)-$20.73M
2015-06-30$3.74M(m)$2.00M-$39.98M
2014-06-30$6.09M(m)$6.47M-$7.46M
2013-06-30$6.28M(m)$5.80M-$6.26M
2012-06-30$14.71M(m)$9.74M-$660.72K
2011-06-30$526.40K(m)$6.20M-$11.71M
2010-06-30$12.66M(m)$4.71M$2.69M

Revenue and expense 9 month

Period endRevenueRevenue including taxResearch and developmentNet income
2025-09-30$8.30M(m)(m)-$26.94M
2024-09-30$7.56M(m)(m)-$33.77M
2023-09-30$7.33M(m)(m)-$35.70M
2022-09-30$7.28M(m)(m)-$45.34M
2021-09-30$7.51M(m)(m)-$31.82M
2020-09-30$7.81M(m)(m)-$22.39M
2019-09-30$6.72M$6.72M(m)-$23.53M
2018-09-30(m)$7.67M(m)-$26.63M
2017-09-30$6.64M$6.64M(m)-$45.29M
2016-09-30$5.17M(m)(m)-$49.08M
2015-09-30$5.79M(m)(m)-$45.52M
2014-09-30$7.85M(m)$10.18M-$13.04M
2013-09-30$13.48M(m)$9.97M-$8.12M
2012-09-30$15.29M(m)$12.78M-$4.05M
2011-09-30$673.53K(m)$9.24M-$15.92M
2010-09-30$15.90M(m)$7.72M$1.17M

Revenue and expense 12 month

Period endRevenueResearch and developmentIncome taxNet income
2025-12-31$9.44M(m)$0.00-$7.58M
2024-12-31$10.91M(m)$0.00-$43.39M
2023-12-31$10.02M(m)(m)-$47.41M
2022-12-31$10.16M(m)(m)-$56.67M
2021-12-31$10.65M(m)(m)-$45.44M
2020-12-31$10.84M(m)(m)-$29.91M
2019-12-31$10.00M(m)(m)-$32.14M
2018-12-31$10.43M(m)(m)-$32.58M
2017-12-31$9.90M(m)(m)-$53.32M
2016-12-31$7.53M$18.00M(m)-$60.41M
2015-12-31$7.88M(m)(m)-$58.98M
2014-12-31$9.84M$13.66M(m)-$18.73M
2013-12-31$15.00M$12.93M(m)-$12.32M
2012-12-31$16.97M$15.49M(m)-$16.42M
2011-12-31$14.76M$13.69M(m)-$9.86M
2010-12-31$16.00M$11.37M(m)-$4.44M
2009-12-31$8.59M$9.93M(m)-$9.82M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70